You are here: Industry Insights > COVID-19

News List

Unvaccinated Belgian woman contracted two COVID variants simultaneously firstwordpharma
July 12, 2021
A patient who died from COVID-19 in March had contracted two variants of coronavirus at the same time, as reported in the National Post, noting it is believed to be the first documented case of its kind.
Australia’s Delta Outbreak Data Show Vaccines Protect Against Hospitalization firstwordpharma
July 12, 2021
Early data from Australia's outbreak of the COVID-19 Delta variant suggest that two vaccine doses offer significant protection against severe illness and hospitalization, reported The Wall Street Journal.
Cybersecurity Market with COVID-19 Impact Analysis by Component, Software, Security Type, Deployment Mode, Organization Size, Vertical and Region - Global Forecast to 2026 prnewswire
July 12, 2021
In the post-COVID-19 scenario, the global cybersecurity market size is projected to grow from USD 217.9 Billion in 2021 to USD 345.4 Billion by 2026, recording a Compound Annual Growth Rate (CAGR) of 9.7% from 2021 to 2026.
Immunexpress Presents Data Supporting SeptiCyte® RAPID for COVID-19 Patient Triage as a Late-Breaking Abstract at ECCMID 2021 prnewswire
July 12, 2021
Immunexpress today announced a late-breaking presentation, titled "Use of SeptiCyte RAPID to assess the risk of ICU admission in COVID-19 patients" (ID#4984), demonstrating the performance of SeptiCyte® RAPID in triaging COVID-19 patients.
COVID-19 Treatment Clinical Landscape Research Report 2021: Pandemic Perspectives - US FDA Wastes No Time In COVID-19 Emergency Use Authorization Reviews prnewswire
July 12, 2021
The commercial outlook for COVID-19 therapeutics is expected to decline progressively throughout 2021 due to the phased implementation of global vaccination programs, which should substantially reduce both outpatient and hospital COVID-19 cases.
$3.7 Billion Worldwide Network Security Firewalls Industry to 2027 - Impact Analysis of COVID-19 prnewswire
July 12, 2021
The "Network Security Firewalls - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.
Study finds lower COVID-19 infection prevalence in fully vaccinated people pharmatimes
July 09, 2021
The latest findings from Imperial College London’s REACT study show that rates of COVID-19 infection are three times lower in fully vaccinated people under the age of 65 compared to unvaccinated people.
BHL gets license from Defence Research and Development Organisation (DRDO) to manufacture and market “2-Deoxy-D-Glucose” (2-DG), used in control & treatment of Covid-19. firstwordpharma
July 09, 2021
Bajaj Healthcare Limited (BHL) a leading manufacturer of APIs, Intermediates and Formulations, has received a licence from DRDO to Manufacture and Market of “2-Deoxy-D-Glucose” (2-DG) as approved medication for the treatment of COVID-19 patients.
KAIST, Institut Pasteur researchers find repurposed drugs for Covid-19 pharmaceutical-technology
July 09, 2021
A research team from the Korea Advanced Institute of Science and Technology (KAIST) and Institut Pasteur Korea has detected repurposed therapies for the treatment of Covid-19 via virtual screening and cell-based tests.
QUT discovers new anticoagulant drug target for Covid-19 pharmaceutical-technology
July 09, 2021
A research team at the Queensland University of Technology (QUT) in Australia has discovered a new binding site on the SARS-CoV-2 spike (S) protein, which could be used as a target for anticoagulant drugs.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page